Jan 22 (Reuters) - Sanofi Chief financial officer Jerome Contamine says :
* sees commercial, cost and tax synergies related to the acquisition of U.S firm Bioverativ by Franceâ€™s Sanofi Further company coverage: (Paris Newsroom)
 